Cart summary

You have no items in your shopping cart.

Mubritinib

SKU: orb1301053
FeaturedFeatured Product

Description

Mubritinib

Research Area

Cardiovascular Research, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology

Images & Validation

Key Properties

CAS Number366017-09-6
MW468.47
Purity99.85%
FormulaC25H23F3N4O2
SMILESFC(F)(F)c1ccc(\C=C\c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1
TargetPDGFR,JAK,FGFR,EGFR
Solubility10% DMSO+90% Corn Oil:2 mg/mL (4.27 mM);DMSO:35.1 mg/mL (74.92 mM)

Bioactivity

Target IC50
HER2/ErbB2:6.0 nM
In Vivo
Mubritinib significantly inhibits LN-REC4 xenograft with treatment/control tumor volume ratio of 26.5%. Although i effective to inhibi the growth of UMUC-3 and ACHN cells in vitro IC50 of 1.812 and >25 μM, respectively , oral administration of Mubritinib (10 or 20 mg/kg per day) significantly inhibit the growth of UMUC-3 and ACHN xenografts with treatment/control tumor volume ratio of 22.9% and 26%, respectively as compared with Herceptin (20 mg/kg) which is i effective to UMUC-3 tumor growth.
In Vitro
Mubritinib displays > 4000-fold selectivity over Other tyrosine kinases, such as EGFR, FGFR, PDGFR, Jak1, Src and Blk. Mubritinib even at low concentration of 0.1 μM significantly blocks HER2 phosphorylation, leading to the downregulation of PI3K-Akt and MAPK pathway in cell line BT474 with high level of HER2. Mubritinib not only exhibits highly potent ant Proliferative effect in ErbB2-overexpressing cancer cell line BT474 with an IC50 of 5 nM, but also displays marked ant Proliferative effects in cell lines with HER2 expressed weakly with IC50 of 53 nM, 90 nM and 91 nM for LNCaP, LN-REC4 and T24, respectively Mubritinib displays no inhibitory activities against PC-3 cells with HER2 expressed very faintly with IC50 of 4.62 μM, as well as EGFR-overexpressing HT1376 and ACHN cell lines with IC50 of >25 μM.
Cell Research
Cells are seeded into 6-well plates and cultured overnight. Mubritinib is then added at various concentration , an the cells are treated continuously for 72 hours. Afte the incubation period, cells are counted fo the measurement of ant Proliferative activity.(Only for Reference)

Storage & Handling

Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
DisclaimerFor research use only

Alternative Names

PDGFR, JAK1, inhibit, Mubritinib, Inhibitor, HER2/ErbB2, HER1, ErbB-1, Epidermal growth factor receptor, EGFR, FGFR, TAK165, TAK-165, TAK 165

Similar Products

  • Mubritinib [orb1222320]

    >98% (HPLC)

    366017-09-6

    468.5

    C25H23F3N4O2

    1 g, 500 mg, 10 mg, 200 mg, 25 mg, 50 mg, 100 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download
MSDS
Safety Data Sheet
Download

Request a Document

Protocol Information

Mubritinib (orb1301053)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

5 mg
$ 80.00
10 mg
$ 100.00
1 ml x 10 mM (in DMSO)
$ 110.00
25 mg
$ 150.00
50 mg
$ 240.00
100 mg
$ 410.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry